113 related articles for article (PubMed ID: 8561975)
21. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.
Cosma A; Blanc D; Braun J; Quillent C; Barassi C; Moog C; Klasen S; Spire B; Scarlatti G; Pesenti E; Siccardi AG; Beretta A
AIDS; 1999 Oct; 13(15):2033-42. PubMed ID: 10546855
[TBL] [Abstract][Full Text] [Related]
22. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
23. Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site.
Dowd CS; Leavitt S; Babcock G; Godillot AP; Van Ryk D; Canziani GA; Sodroski J; Freire E; Chaiken IM
Biochemistry; 2002 Jun; 41(22):7038-46. PubMed ID: 12033937
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain.
Lopalco L; De Santis C; Meneveri R; Longhi R; Ginelli E; Grassi F; Siccardi AG; Beretta A
Eur J Immunol; 1993 Aug; 23(8):2016-21. PubMed ID: 8344367
[TBL] [Abstract][Full Text] [Related]
25. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120.
Sakihama T; Smolyar A; Reinherz EL
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6444-8. PubMed ID: 7604010
[TBL] [Abstract][Full Text] [Related]
26. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
Neurath AR; Strick N; Li YY; Jiang S
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
[TBL] [Abstract][Full Text] [Related]
27. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
Clayton LK; Sieh M; Pious DA; Reinherz EL
Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
[TBL] [Abstract][Full Text] [Related]
28. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120.
Merkenschlager M; Buck D; Beverley PC; Sattentau QJ
J Immunol; 1990 Nov; 145(9):2839-45. PubMed ID: 1698863
[TBL] [Abstract][Full Text] [Related]
29. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
30. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
[TBL] [Abstract][Full Text] [Related]
31. Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule.
Lamarre D; Capon DJ; Karp DR; Gregory T; Long EO; Sékaly RP
EMBO J; 1989 Nov; 8(11):3271-7. PubMed ID: 2555159
[TBL] [Abstract][Full Text] [Related]
32. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors.
Chersi A; Pugliese O; Federico A; Viora M
Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301
[TBL] [Abstract][Full Text] [Related]
33. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
34. Structure-based design of peptides that recognize the CD4 binding domain of HIV-1 gp120.
Fontenot JD; Tan X; Phillips DM
AIDS; 1998 Aug; 12(12):1413-8. PubMed ID: 9727561
[TBL] [Abstract][Full Text] [Related]
35. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
[TBL] [Abstract][Full Text] [Related]
36. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
37. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
38. [Planar molecular arrangements aid the design of MHC class II binding peptides].
Cortés A; Coral J; McLachlan C; Benítez R; Pinilla L
Mol Biol (Mosk); 2017; 51(3):524-533. PubMed ID: 28707669
[TBL] [Abstract][Full Text] [Related]
39. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
Cohen S; Tuen M; Hioe CE
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
[TBL] [Abstract][Full Text] [Related]
40. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.
Fernandez MH; Faith A; Higgins JA; Weber J; Rees AD
Immunology; 1995 Jun; 85(2):176-83. PubMed ID: 7642208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
